SEIKAGAKU CORP chart

Last update: 2021-02-19
Key statistics and financials
Revenue per share 558.08
Dividend & Yield22.00¥ (2.44%)
Beta 0.29
Market capitalization 48.73B
Operating cash flow N/A
ESG Scores unknown

Company description

Seikagaku Corporation manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally. The company operates in two segments, Pharmaceuticals and LAL. It offers pharmaceuticals and medical devices, including intra-articular injections for improving joint functions under the brands of ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX; ophthalmic surgical aids under the OPEGAN, OPEGAN Hi, and SHELLGAN brands; surgical aids for endoscopic mucosal resection under the brand name of MucoUp; and cross-linked hyaluronate hydrogel for knee osteoarthritis under the brand name Gel-One, as well as HERNICORE for the treatment of lumbar disc herniation. The company also offers bulk products comprising sodium hyaluronate and sodium chondroitin sulfate for use in pharmaceuticals and cosmetics. In addition, it develops endotoxin-detecting reagents for use in quality control of injectable pharmaceuticals, biological products, medical devices, manufacturing processes, and water quality control of dialysate under the brands, such as Pyrochrome, ENDOSPECY, TOXICOLOR, etc. Further, the company develops and markets oral care products comprising mouthwash under the KINUSUI Spray brand. Additionally, its products under development include SI-6603 for lumbar disc herniation; SI-614, a modified hyaluronate for dry eyes; SI-613 for osteoarthritis; SI-613-ETP to treat enthesopathy; and SI-449, a powdered adhesion barrier. The company was formerly known as K.K. Seikagaku Kenkyusho and changed its name to Seikagaku Corporation in 1962. Seikagaku Corporation was founded in 1947 and is headquartered in Tokyo, Japan.

Sector: Healthcare - Industry: Medical Devices

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities -1.98B -28M -676M 666M
Total Cashflows From Investing Activities -1.48B 623M 1.02B 870M
Net Borrowings 158M 76M -87M -87M
Total Cash From Financing Activities -1.81B -1.6B -1.51B -2.15B
Change To Operating Activities 989M 931M 150M -37M
Issuance Of Stock
Net Income 2.24B -10.84B 4.26B 3.73B
Change In Cash -198M 7.68B 775M 7.6B
Effect Of Exchange Rate -25M -11M 1M 689M
Total Cash From Operating Activities 3.12B 8.67B 1.26B 8.19B
Depreciation 2.9B 1.78B 808M 1.05B
Change To Account Receivables 384M 2.3B -957M 1.2B
Other Cashflows From Financing Activities -199M -213M -210M -210M
Change To Netincome -2.03B 13.39B -525M -133M
Capital Expenditures -1.18B -1.67B -1.89B -1.84B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development 7.15B 6.88B 7.21B 9.01B
Income Before Tax 2.86B -9.54B 3.02B 5.39B
Net Income 2.24B -10.84B 4.26B 3.73B
Selling General Administrative 7.14B 7.29B 6.81B 7.03B
Gross Profit 15.27B 16.13B 15.55B 20.53B
Ebit 978M 1.96B 1.53B 4.5B
Operating Income 978M 1.96B 1.53B 4.5B
Interest Expense -22M -18M -16M -11M
Income Tax Expense 614M 1.3B -1.24B 1.66B
Total Revenue 28.38B 28.64B 27.66B 34.85B
Cost Of Revenue 13.11B 12.51B 12.11B 14.32B
Total Other Income ExpenseNet 1.88B -11.5B 1.49B 899M
Net Income From Continuing Ops 2.24B -10.84B 4.26B 3.73B
Net Income Applicable To Common Shares 2.24B -10.84B 4.26B 3.73B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 7.2B 8.73B 6.31B 8.9B
Total Stockholder Equity 73.03B 59.77B 63.6B 66.34B
Other Current Liabilities 3.68B 5.04B 3.91B 5.86B
Total Assets 80.24B 68.5B 69.92B 75.24B
Common Stock 3.84B 3.84B 3.84B 3.84B
Other Current Assets 1.85B 5.49B 2.1B 2B
Retained Earnings 60.57B 48.25B 51.21B 53.3B
Treasury Stock 3.33B 2.37B 3.25B 3.89B
Cash 8.99B 13.1B 15.19B 21.52B
Total Current Liabilities 5.36B 6.71B 5.61B 7.53B
Other Stockholder Equity 3.98B 3B 3.85B 4.7B
Property, Plant, and Equipment 19.66B 7.66B 8.3B 10.02B
Total Current Assets 34.39B 40.45B 43.56B 48.62B
Net Tangible Assets 72.46B 58.19B 61.25B 63.41B
Net Receivables 8.29B 6.1B 6.98B 5.87B
Accounts Payable 721M 613M 670M 680M


Insider Transactions

Here are the insider transactions of stock shares related to SEIKAGAKU CORP:

Filer Name Transaction Text Ownership Date Filer Relation Shares
NO DATA

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SEIKAGAKU CORP. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SEIKAGAKU CORP

Here is the result of two systematic investment strategies applied to SEIKAGAKU CORP. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SEIKAGAKU CORP

The following chart shows the equity curve of the two systematic investment strategies applied to SEIKAGAKU CORP:

SEIKAGAKU CORP automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -34.38% on the backtest period.

Performance at glance

Performance

-34.38 %

Latent gain

-3364.0 ¥

Invested capital

9784.0 ¥

Annualized return

-8.19 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SEIKAGAKU CORP

This is the result of two momentum investment strategies applied to SEIKAGAKU CORP. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SEIKAGAKU CORP

The following chart shows all the entries opened by the momentum investment system on SEIKAGAKU CORP:

SEIKAGAKU CORP momentum entries
  • The first momentum investment strategy would give -40.59% of return on SEIKAGAKU CORP. That represents -3655.0¥ of latent gain with 9005.0¥ of employed capital.
  • The second momentum investment strategy would give -31.47% of return on SEIKAGAKU CORP. That represents -2948.0¥ of latent gain with 9368.0¥ of employed capital.
Performance at glance (1Q Momentum)

Performance

-40.59 %

Latent gain

-3655.0 ¥

Invested capital

9005.0 ¥

Annualized return

2.69 %
Performance at glance (2Q Momentum)

Performance

-31.47 %

Latent gain

-2948.0 ¥

Invested capital

9368.0 ¥

Annualized return

-8.46 %

Momentum equity curve on SEIKAGAKU CORP

The following chart shows the equity curve of the two momentum strategies applied to SEIKAGAKU CORP:

SEIKAGAKU CORP momentum equity

Note: the dividends potentially given by SEIKAGAKU CORP are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SEIKAGAKU CORP

The following chart shows the employed capital evolution of the two momentum strategies on SEIKAGAKU CORP since the beginning:

SEIKAGAKU CORP

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250¥, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000¥.


Buy the dip strategy result on SEIKAGAKU CORP

Buy the dip entry openings on SEIKAGAKU CORP

SEIKAGAKU CORP

The performance achieved by the robo-advisor on SEIKAGAKU CORP is 5.91%. That represents 179.0$ of latent gain with 3031.0¥ of employed capital. The following chart shows SEIKAGAKU CORP stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SEIKAGAKU CORP, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

5.91 %

Latent gain

179.0 ¥

Invested capital

3031.0 ¥

Annualized return

2.69 %

Equity curve of the strategy applied to SEIKAGAKU CORP

The following chart shows the result of the investment strategy applied to SEIKAGAKU CORP:

SEIKAGAKU CORP

Note: the dividends potentially given by SEIKAGAKU CORP are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SEIKAGAKU CORP

The following chart shows the employed capital evolution since the beginning of the investment strategy on SEIKAGAKU CORP:

SEIKAGAKU CORP

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SEIKAGAKU CORP

In this section, I will compare the three previous investment strategies applied to SEIKAGAKU CORP.

Equity curve comparison on SEIKAGAKU CORP

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SEIKAGAKU CORP investment strategy comparison

Employed capital comparison on SEIKAGAKU CORP

SEIKAGAKU CORP investment comparison

Performance comparison on SEIKAGAKU CORP

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -34.38% -3364.0¥ 9784.0¥ -8.19%
Momentum 1 quarter -40.59% -3655.0¥ 9005.0¥ -10.25%
Momentum 2 quarters -31.47% -2948.0¥ 9368.0¥ -8.46%
Non-directional 5.91% 179.0¥ 3031.0¥ 2.69%
Annualized return comparison

Automatic investment

-8.19 %

Momentum 1Q

-8.46 %

Momentum 2Q

-8.46 %

Non-directional

2.69 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SEIKAGAKU CORP:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between SEIKAGAKU CORP and the other stocks. There may be false positives or some missing correlated stocks. If the price of SEIKAGAKU CORP does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name SEIKAGAKU CORP
Country Japan
City Tokyo
Address Marunouchi Center Building
Phone 81 3 5220 8950
Website www.seikagaku.co.jp
FullTime employees 937
Industry Medical Devices
Sector Healthcare
Exchange XTKS
Ticker 4548.XTKS
Market www.jpx.co.jp

SEIKAGAKU CORP ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown